Influenza vaccination coverage among high-risk groups in 11 European countries
Influenza vaccination coverage among high-risk groups in 11 European countries
复制标题
DOI：
10.1093/eurpub/ckr094
复制
发表时间：
2012-08-01
影响因子：
4.4
通讯作者：
Apfelbacher, Christian J.
中科院分区：
文献类型：
--
作者：
Loerbroks, Adrian;Stock, Christian;Apfelbacher, Christian J.
背景：流感相关并发症风险增加的个人的全国疫苗接种覆盖率代表了一个有用的公共卫生准备指标。我们比较了欧洲国家的以下方面：(i) 高风险人群的疫苗接种覆盖率；以及 (ii) 高风险人群与低风险人群相比报告流感疫苗接种的可能性。方法：我们使用 2004 年 5 月收集的欧洲健康、老龄化和退休调查 (SHARE) 数据。来自 11 个国家的 50 岁成年人提供了上一年流感疫苗接种情况的自我报告（n = 16 913）。我们定义了四个高风险群体（年龄 65 岁、存在血管疾病、慢性肺病或糖尿病），并以 95% 置信区间计算了每个国家的疫苗接种覆盖率。使用特定国家的多变量逻辑回归来估计高风险群体成员资格和疫苗接种的比值比 (OR)。结果：荷兰在高危群体中的流感疫苗接种覆盖率最高（任何组中的 epsilon 75%），而希腊最低（任何组中 < 27%）。在所有国家中，年龄较大与疫苗接种报告呈正相关，但这种关联的强度从 OR < 2（德国）到 > 13（荷兰）不等。荷兰慢性病组的 OR 为 epsilon 4，而其他国家的 OR 则低得多（通常不具有统计显着性）。结论：欧洲国家之间高危人群的流感疫苗接种覆盖率差异很大。我们的研究结果强调了通过支持更有效地针对高危人群的疫苗接种计划来减少流感相关并发症的潜在机会。
Background: National vaccination coverage rates for individuals at increased risk of influenza-related complications represent a useful public health indicator of preparedness. We compared European countries regarding (i) vaccination coverage among high-risk groups and (ii) the likelihood that high-risk individuals reported influenza vaccination compared with those at lower risk. Methods: We used data from the Survey of Health, Ageing and Retirement in Europe (SHARE) collected in 2004-05. Adults aged epsilon 50 years from 11 countries provided self-reports of an influenza vaccination in the previous year (n = 16 913). We defined four high-risk groups (age epsilon 65 years, presence of vascular disease, chronic lung disease or diabetes) and calculated vaccination coverage with 95% confidence intervals for each country. Country-specific multivariable logistic regression was used to estimate odds ratios (ORs) for membership in a high-risk group and vaccination. Results: The Netherlands had the highest influenza vaccination coverage in high-risk groups (epsilon 75% in any group) while Greece had the lowest (< 27% in any group). Older age was positively associated with report of vaccination in all countries, but the strength of this association varied from an OR of < 2 (Germany) to > 13 (The Netherlands). The ORs for the chronic disease groups was epsilon 4 for The Netherlands and were considerably lower (and often not statistically significant) for the other countries. Conclusion: Influenza vaccination coverage among high-risk groups varies considerably between European countries. Our findings highlight potential opportunities for reducing influenza-related complications through support for vaccination programs that target high-risk individuals more effectively.